PPR-148 - A multisite implementation-efficacy trial of a community pharmacist-led model of collaborative care for medication assisted treatment for opioid dependence: 6-month outcomes of the EPIC-MATOD trial

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-148
• By: NIELSEN, Suzanne (Monash University, Australia)
• Co-author(s): Prof Suzanne Nielsen (Monash University, Melbourne, Australia)
  Dr Ali Cheetham (Monash University, Melbourne, Australia)
  
• Abstract:

  Introduction: Opioid dependence treatment which includes methadone, buprenorphine, and buprenorphine-naloxone (previously commonly referred to as Medication Assisted Treatment for Opioid Dependence [MATOD]), is considered the gold standard for treatment for opioid use disorder. Australia faces a critical challenge with access to opioid dependence..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login